| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Density | 237 | 2024 | 3551 | 15.020 |
Why?
|
| Bone and Bones | 106 | 2024 | 2568 | 7.880 |
Why?
|
| Osteoporosis | 69 | 2024 | 1606 | 7.820 |
Why?
|
| Spinal Fractures | 28 | 2024 | 705 | 5.520 |
Why?
|
| Absorptiometry, Photon | 90 | 2024 | 1738 | 5.350 |
Why?
|
| Lumbar Vertebrae | 56 | 2023 | 1879 | 4.720 |
Why?
|
| Osteoporotic Fractures | 18 | 2024 | 411 | 4.650 |
Why?
|
| Spine | 36 | 2023 | 1118 | 4.520 |
Why?
|
| Hip Fractures | 23 | 2024 | 988 | 4.200 |
Why?
|
| Tibia | 47 | 2024 | 1070 | 4.110 |
Why?
|
| Radius | 43 | 2024 | 441 | 4.000 |
Why?
|
| Thoracic Vertebrae | 20 | 2019 | 597 | 3.840 |
Why?
|
| Femur Neck | 22 | 2024 | 314 | 3.580 |
Why?
|
| Bone Density Conservation Agents | 29 | 2024 | 795 | 3.410 |
Why?
|
| Fractures, Bone | 44 | 2024 | 2046 | 3.360 |
Why?
|
| Weight-Bearing | 32 | 2024 | 532 | 3.300 |
Why?
|
| Femur | 50 | 2024 | 1307 | 2.940 |
Why?
|
| Space Flight | 13 | 2024 | 215 | 2.870 |
Why?
|
| Bone Resorption | 24 | 2022 | 723 | 2.760 |
Why?
|
| Bone Diseases, Metabolic | 17 | 2022 | 409 | 2.550 |
Why?
|
| Fractures, Stress | 11 | 2022 | 202 | 2.480 |
Why?
|
| Radius Fractures | 11 | 2022 | 515 | 2.380 |
Why?
|
| X-Ray Microtomography | 30 | 2024 | 456 | 2.340 |
Why?
|
| Osteogenesis | 40 | 2022 | 1273 | 2.070 |
Why?
|
| Finite Element Analysis | 22 | 2020 | 438 | 2.040 |
Why?
|
| Diphosphonates | 15 | 2022 | 636 | 1.960 |
Why?
|
| Tomography, X-Ray Computed | 94 | 2024 | 20570 | 1.860 |
Why?
|
| Osteocytes | 12 | 2023 | 192 | 1.790 |
Why?
|
| Parathyroid Hormone | 25 | 2022 | 1803 | 1.740 |
Why?
|
| Military Personnel | 11 | 2024 | 1246 | 1.720 |
Why?
|
| Bone Remodeling | 30 | 2022 | 581 | 1.650 |
Why?
|
| Muscle, Skeletal | 19 | 2024 | 4948 | 1.610 |
Why?
|
| Hindlimb Suspension | 11 | 2024 | 75 | 1.610 |
Why?
|
| Bone Development | 12 | 2019 | 472 | 1.600 |
Why?
|
| Postmenopause | 13 | 2021 | 2513 | 1.540 |
Why?
|
| Osteoporosis, Postmenopausal | 15 | 2022 | 396 | 1.520 |
Why?
|
| Osteoblasts | 37 | 2022 | 1143 | 1.440 |
Why?
|
| Teriparatide | 12 | 2023 | 227 | 1.430 |
Why?
|
| Wrist Injuries | 7 | 2023 | 214 | 1.350 |
Why?
|
| Vertebroplasty | 3 | 2019 | 78 | 1.280 |
Why?
|
| Bone Diseases | 5 | 2022 | 418 | 1.180 |
Why?
|
| Female | 286 | 2024 | 392644 | 1.170 |
Why?
|
| Compressive Strength | 11 | 2020 | 158 | 1.150 |
Why?
|
| Ovariectomy | 13 | 2023 | 614 | 1.030 |
Why?
|
| Parathyroid Hormone-Related Protein | 6 | 2023 | 327 | 1.020 |
Why?
|
| Muscular Atrophy | 5 | 2024 | 334 | 1.020 |
Why?
|
| Fractures, Compression | 3 | 2019 | 131 | 0.980 |
Why?
|
| Weightlessness | 6 | 2024 | 102 | 0.960 |
Why?
|
| Aged | 133 | 2024 | 169289 | 0.910 |
Why?
|
| Arrestins | 5 | 2009 | 73 | 0.910 |
Why?
|
| Humans | 310 | 2024 | 761504 | 0.900 |
Why?
|
| Bone Morphogenetic Proteins | 15 | 2013 | 842 | 0.900 |
Why?
|
| Male | 205 | 2024 | 360804 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2022 | 12148 | 0.870 |
Why?
|
| Aged, 80 and over | 81 | 2024 | 58976 | 0.860 |
Why?
|
| Sex Characteristics | 12 | 2018 | 2639 | 0.850 |
Why?
|
| Pelvic Bones | 4 | 2020 | 270 | 0.810 |
Why?
|
| Glycoproteins | 8 | 2018 | 2203 | 0.810 |
Why?
|
| Calcaneus | 7 | 2002 | 142 | 0.800 |
Why?
|
| Premenopause | 4 | 2022 | 1039 | 0.780 |
Why?
|
| Caloric Restriction | 3 | 2018 | 299 | 0.780 |
Why?
|
| Musculoskeletal System | 2 | 2021 | 188 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 58 | 2024 | 22169 | 0.770 |
Why?
|
| Animals | 155 | 2024 | 168459 | 0.760 |
Why?
|
| Body Weight | 19 | 2023 | 4618 | 0.760 |
Why?
|
| Bone Regeneration | 6 | 2020 | 432 | 0.760 |
Why?
|
| Organ Size | 18 | 2019 | 2254 | 0.760 |
Why?
|
| Stress, Mechanical | 15 | 2022 | 1674 | 0.740 |
Why?
|
| Middle Aged | 119 | 2024 | 220895 | 0.740 |
Why?
|
| Alendronate | 6 | 2021 | 175 | 0.740 |
Why?
|
| Calcium Phosphates | 4 | 2019 | 171 | 0.720 |
Why?
|
| Amenorrhea | 9 | 2021 | 483 | 0.700 |
Why?
|
| Mice | 107 | 2024 | 81525 | 0.700 |
Why?
|
| Aging | 23 | 2024 | 8708 | 0.680 |
Why?
|
| Adipose Tissue | 11 | 2023 | 3312 | 0.680 |
Why?
|
| Insulin-Like Growth Factor I | 15 | 2021 | 1934 | 0.670 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 8 | 2022 | 305 | 0.660 |
Why?
|
| Calcium Sulfate | 1 | 2019 | 24 | 0.660 |
Why?
|
| Body Composition | 20 | 2024 | 2426 | 0.660 |
Why?
|
| Gastric Bypass | 5 | 2022 | 818 | 0.650 |
Why?
|
| Fractures, Spontaneous | 4 | 2010 | 231 | 0.650 |
Why?
|
| Kyphoplasty | 2 | 2019 | 44 | 0.640 |
Why?
|
| Kyphosis | 4 | 2019 | 237 | 0.630 |
Why?
|
| Fracture Healing | 9 | 2009 | 445 | 0.620 |
Why?
|
| Imidazoles | 6 | 2014 | 1180 | 0.620 |
Why?
|
| Astronauts | 1 | 2019 | 92 | 0.620 |
Why?
|
| Advisory Committees | 2 | 2019 | 787 | 0.620 |
Why?
|
| Anorexia Nervosa | 8 | 2022 | 1361 | 0.610 |
Why?
|
| Menstruation | 6 | 2024 | 307 | 0.610 |
Why?
|
| Activin Receptors, Type II | 2 | 2009 | 123 | 0.610 |
Why?
|
| Accidental Falls | 9 | 2015 | 1068 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 11 | 2010 | 1961 | 0.560 |
Why?
|
| Cross-Linking Reagents | 2 | 2010 | 687 | 0.560 |
Why?
|
| Cadaver | 12 | 2018 | 1358 | 0.550 |
Why?
|
| Posture | 5 | 2022 | 957 | 0.550 |
Why?
|
| Leptin | 4 | 2023 | 1597 | 0.520 |
Why?
|
| Bone Marrow | 6 | 2022 | 2911 | 0.520 |
Why?
|
| Models, Biological | 15 | 2022 | 9469 | 0.510 |
Why?
|
| Osteoclasts | 15 | 2022 | 711 | 0.500 |
Why?
|
| Cross-Sectional Studies | 36 | 2024 | 26125 | 0.500 |
Why?
|
| Lactation | 2 | 2019 | 397 | 0.490 |
Why?
|
| Physicians, Women | 1 | 2021 | 508 | 0.490 |
Why?
|
| Adult | 95 | 2024 | 221177 | 0.490 |
Why?
|
| Case-Control Studies | 19 | 2022 | 22176 | 0.490 |
Why?
|
| Femoral Neck Fractures | 3 | 2014 | 142 | 0.480 |
Why?
|
| Back Pain | 1 | 2019 | 545 | 0.480 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2021 | 1208 | 0.470 |
Why?
|
| Mars | 3 | 2023 | 28 | 0.470 |
Why?
|
| Muscle Strength | 4 | 2019 | 624 | 0.460 |
Why?
|
| Collagen | 5 | 2012 | 2638 | 0.460 |
Why?
|
| Age Factors | 14 | 2024 | 18395 | 0.450 |
Why?
|
| Exercise | 14 | 2023 | 5890 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2024 | 3415 | 0.450 |
Why?
|
| Gastrectomy | 7 | 2023 | 672 | 0.450 |
Why?
|
| Calcification, Physiologic | 4 | 2018 | 170 | 0.450 |
Why?
|
| Muscle Weakness | 1 | 2017 | 412 | 0.450 |
Why?
|
| Tibial Fractures | 1 | 2017 | 273 | 0.450 |
Why?
|
| Inheritance Patterns | 4 | 2017 | 341 | 0.440 |
Why?
|
| Strepsirhini | 1 | 2013 | 2 | 0.440 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 169 | 0.440 |
Why?
|
| Risk Factors | 39 | 2024 | 74206 | 0.430 |
Why?
|
| Young Adult | 43 | 2024 | 59243 | 0.420 |
Why?
|
| Muscles | 8 | 2024 | 1576 | 0.410 |
Why?
|
| Etidronic Acid | 2 | 2010 | 63 | 0.410 |
Why?
|
| Estrone | 2 | 2023 | 234 | 0.400 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 189 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 10 | 2018 | 1651 | 0.390 |
Why?
|
| Collagen Type I | 7 | 2024 | 616 | 0.380 |
Why?
|
| Femoral Fractures | 4 | 2019 | 375 | 0.380 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 4 | 2022 | 68 | 0.380 |
Why?
|
| Hip | 6 | 2024 | 255 | 0.380 |
Why?
|
| RNA | 1 | 2021 | 2726 | 0.380 |
Why?
|
| Estradiol | 7 | 2024 | 1937 | 0.370 |
Why?
|
| Pressure | 5 | 2023 | 1154 | 0.360 |
Why?
|
| Mechanical Phenomena | 2 | 2013 | 141 | 0.360 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2014 | 1119 | 0.360 |
Why?
|
| Radiography | 15 | 2023 | 6965 | 0.360 |
Why?
|
| Porosity | 8 | 2017 | 349 | 0.360 |
Why?
|
| Sex Factors | 15 | 2018 | 10552 | 0.350 |
Why?
|
| Macaca fascicularis | 5 | 2010 | 903 | 0.350 |
Why?
|
| Fibronectins | 3 | 2020 | 723 | 0.350 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2011 | 160 | 0.340 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2013 | 389 | 0.330 |
Why?
|
| Rats | 21 | 2024 | 23742 | 0.330 |
Why?
|
| Gene Expression | 3 | 2021 | 7581 | 0.330 |
Why?
|
| Diabetes Complications | 2 | 2014 | 1315 | 0.320 |
Why?
|
| Athletes | 8 | 2022 | 1137 | 0.320 |
Why?
|
| Prospective Studies | 23 | 2024 | 54425 | 0.320 |
Why?
|
| Thorax | 1 | 2011 | 555 | 0.310 |
Why?
|
| Arginine | 3 | 2019 | 934 | 0.310 |
Why?
|
| Alkaline Phosphatase | 6 | 2018 | 864 | 0.300 |
Why?
|
| Ulna Fractures | 4 | 2007 | 126 | 0.300 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2008 | 242 | 0.300 |
Why?
|
| Adolescent | 41 | 2023 | 88319 | 0.290 |
Why?
|
| Mice, Knockout | 27 | 2021 | 14414 | 0.290 |
Why?
|
| Tomography Scanners, X-Ray Computed | 4 | 2018 | 173 | 0.290 |
Why?
|
| Lysine | 3 | 2019 | 993 | 0.290 |
Why?
|
| Cystic Fibrosis | 4 | 2021 | 1285 | 0.290 |
Why?
|
| Gravity, Altered | 2 | 2024 | 10 | 0.280 |
Why?
|
| Procollagen | 4 | 2024 | 187 | 0.280 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 1469 | 0.280 |
Why?
|
| Recombinant Proteins | 10 | 2016 | 6534 | 0.280 |
Why?
|
| Elasticity | 5 | 2016 | 655 | 0.280 |
Why?
|
| Incidence | 8 | 2024 | 21353 | 0.280 |
Why?
|
| Models, Anatomic | 3 | 2015 | 683 | 0.270 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2024 | 10209 | 0.260 |
Why?
|
| Regression Analysis | 9 | 2020 | 6343 | 0.260 |
Why?
|
| Adipocytes | 5 | 2018 | 1194 | 0.260 |
Why?
|
| Antibodies | 2 | 2017 | 2418 | 0.260 |
Why?
|
| Thigh | 1 | 2007 | 241 | 0.260 |
Why?
|
| Adaptation, Physiological | 4 | 2020 | 1301 | 0.250 |
Why?
|
| Weightlessness Simulation | 2 | 2019 | 41 | 0.250 |
Why?
|
| Knee Joint | 3 | 2023 | 1676 | 0.250 |
Why?
|
| Reproducibility of Results | 14 | 2020 | 20098 | 0.250 |
Why?
|
| Spinal Cord Injuries | 2 | 2024 | 925 | 0.250 |
Why?
|
| Mice, Congenic | 4 | 2004 | 97 | 0.240 |
Why?
|
| Intra-Abdominal Fat | 2 | 2023 | 613 | 0.240 |
Why?
|
| Body Mass Index | 10 | 2023 | 12953 | 0.240 |
Why?
|
| Histone Deacetylases | 3 | 2020 | 719 | 0.240 |
Why?
|
| Periosteum | 3 | 2017 | 139 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2021 | 1642 | 0.240 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1852 | 0.230 |
Why?
|
| Osteolysis | 3 | 2018 | 275 | 0.230 |
Why?
|
| Bone Morphogenetic Protein 2 | 12 | 2012 | 343 | 0.230 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 9539 | 0.230 |
Why?
|
| Linear Models | 8 | 2023 | 5871 | 0.230 |
Why?
|
| Spinal Curvatures | 2 | 2016 | 71 | 0.230 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1762 | 0.220 |
Why?
|
| Risk Assessment | 11 | 2024 | 23995 | 0.220 |
Why?
|
| Whole-Body Irradiation | 1 | 2024 | 433 | 0.220 |
Why?
|
| RANK Ligand | 6 | 2017 | 318 | 0.220 |
Why?
|
| Signal Transduction | 20 | 2022 | 23445 | 0.220 |
Why?
|
| Extraterrestrial Environment | 1 | 2023 | 25 | 0.220 |
Why?
|
| Durapatite | 2 | 2019 | 163 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2022 | 2898 | 0.220 |
Why?
|
| Age of Onset | 2 | 2024 | 3305 | 0.210 |
Why?
|
| Rabbits | 9 | 2022 | 4772 | 0.210 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11528 | 0.210 |
Why?
|
| Osteotomy | 7 | 2007 | 837 | 0.210 |
Why?
|
| Spinal Injuries | 1 | 2006 | 301 | 0.210 |
Why?
|
| Algorithms | 7 | 2016 | 14031 | 0.210 |
Why?
|
| Fibroblast Growth Factors | 4 | 2018 | 867 | 0.210 |
Why?
|
| Models, Animal | 8 | 2021 | 2112 | 0.210 |
Why?
|
| Models, Theoretical | 2 | 2008 | 3575 | 0.210 |
Why?
|
| Anatomy, Cross-Sectional | 2 | 2014 | 141 | 0.210 |
Why?
|
| Obesity | 9 | 2023 | 12947 | 0.210 |
Why?
|
| Disease Models, Animal | 14 | 2019 | 18252 | 0.200 |
Why?
|
| Estrogens | 4 | 2023 | 1522 | 0.200 |
Why?
|
| Fasting | 2 | 2021 | 1603 | 0.200 |
Why?
|
| Calcium | 10 | 2023 | 5722 | 0.200 |
Why?
|
| Manometry | 1 | 2024 | 454 | 0.200 |
Why?
|
| Muscular Disorders, Atrophic | 1 | 2021 | 24 | 0.190 |
Why?
|
| Electric Impedance | 3 | 2014 | 757 | 0.190 |
Why?
|
| Overweight | 1 | 2013 | 2417 | 0.190 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2021 | 32 | 0.190 |
Why?
|
| Female Athlete Triad Syndrome | 1 | 2022 | 62 | 0.190 |
Why?
|
| Ribs | 2 | 2015 | 252 | 0.190 |
Why?
|
| Optic Nerve | 1 | 2024 | 572 | 0.180 |
Why?
|
| Vibration | 2 | 2015 | 328 | 0.180 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2021 | 39 | 0.180 |
Why?
|
| Wound Healing | 3 | 2006 | 2805 | 0.180 |
Why?
|
| Observer Variation | 4 | 2011 | 2606 | 0.180 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 114 | 0.180 |
Why?
|
| Continuity of Patient Care | 1 | 2008 | 1069 | 0.180 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2021 | 60 | 0.180 |
Why?
|
| Quantitative Trait Loci | 6 | 2016 | 2116 | 0.180 |
Why?
|
| Ghrelin | 1 | 2022 | 252 | 0.180 |
Why?
|
| Rats, Wistar | 4 | 2019 | 1848 | 0.180 |
Why?
|
| Cells, Cultured | 15 | 2020 | 18965 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2019 | 829 | 0.180 |
Why?
|
| Aminophenols | 1 | 2021 | 87 | 0.180 |
Why?
|
| Time Factors | 16 | 2024 | 39967 | 0.180 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2012 | 97 | 0.180 |
Why?
|
| TRPM Cation Channels | 1 | 2021 | 139 | 0.180 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2024 | 701 | 0.180 |
Why?
|
| Progesterone | 1 | 2024 | 742 | 0.170 |
Why?
|
| Rodentia | 1 | 2021 | 262 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9177 | 0.170 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 186 | 0.170 |
Why?
|
| Ulna | 4 | 2004 | 134 | 0.170 |
Why?
|
| Hip Joint | 4 | 2014 | 1014 | 0.170 |
Why?
|
| Peptide Fragments | 6 | 2024 | 5112 | 0.170 |
Why?
|
| Heel | 1 | 1999 | 37 | 0.170 |
Why?
|
| Fluorides | 1 | 2020 | 134 | 0.170 |
Why?
|
| Body Temperature Regulation | 1 | 2021 | 292 | 0.170 |
Why?
|
| Cathepsin K | 1 | 2019 | 65 | 0.170 |
Why?
|
| MicroRNAs | 3 | 2022 | 3816 | 0.160 |
Why?
|
| Body Temperature | 1 | 2002 | 781 | 0.160 |
Why?
|
| Multivariate Analysis | 6 | 2018 | 12059 | 0.160 |
Why?
|
| Longitudinal Studies | 12 | 2023 | 14605 | 0.160 |
Why?
|
| Ankle Joint | 1 | 2023 | 446 | 0.160 |
Why?
|
| Range of Motion, Articular | 4 | 2023 | 1588 | 0.160 |
Why?
|
| Integrin alphaV | 1 | 2018 | 54 | 0.160 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 2947 | 0.160 |
Why?
|
| Hindlimb | 1 | 2021 | 513 | 0.160 |
Why?
|
| Movement | 2 | 2016 | 1478 | 0.160 |
Why?
|
| Dendrites | 1 | 2021 | 475 | 0.160 |
Why?
|
| Dwarfism | 1 | 2019 | 138 | 0.160 |
Why?
|
| Tensile Strength | 5 | 2015 | 330 | 0.160 |
Why?
|
| Activins | 2 | 2010 | 210 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2012 | 3734 | 0.160 |
Why?
|
| Gastroplasty | 1 | 2020 | 157 | 0.150 |
Why?
|
| Fingers | 2 | 2003 | 507 | 0.150 |
Why?
|
| Sarcopenia | 1 | 2023 | 372 | 0.150 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 182 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2024 | 2329 | 0.150 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2018 | 58 | 0.150 |
Why?
|
| Superoxide Dismutase | 2 | 2018 | 594 | 0.150 |
Why?
|
| Prostheses and Implants | 3 | 2021 | 1271 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2019 | 1376 | 0.150 |
Why?
|
| Quinolones | 1 | 2021 | 378 | 0.140 |
Why?
|
| Joints | 1 | 2019 | 322 | 0.140 |
Why?
|
| Lipolysis | 1 | 2018 | 212 | 0.140 |
Why?
|
| Age Determination by Skeleton | 1 | 2018 | 126 | 0.140 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 876 | 0.140 |
Why?
|
| Phenotype | 13 | 2022 | 16591 | 0.140 |
Why?
|
| Vitamin D | 9 | 2022 | 3303 | 0.140 |
Why?
|
| Growth Hormone | 3 | 2012 | 569 | 0.140 |
Why?
|
| Gene Deletion | 6 | 2021 | 2665 | 0.140 |
Why?
|
| Obesity, Morbid | 3 | 2018 | 1277 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2018 | 1222 | 0.140 |
Why?
|
| Running | 1 | 2022 | 488 | 0.140 |
Why?
|
| Orthopedics | 1 | 2006 | 898 | 0.140 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 18 | 0.140 |
Why?
|
| Ultrasonography | 10 | 2002 | 5972 | 0.140 |
Why?
|
| Receptor, EphB2 | 1 | 2016 | 26 | 0.140 |
Why?
|
| Genetic Markers | 5 | 2013 | 2601 | 0.140 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2018 | 195 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 4063 | 0.140 |
Why?
|
| Anthropometry | 3 | 2018 | 1349 | 0.140 |
Why?
|
| Sports | 2 | 2013 | 705 | 0.130 |
Why?
|
| Calcitriol | 2 | 2016 | 296 | 0.130 |
Why?
|
| Predictive Value of Tests | 8 | 2018 | 15266 | 0.130 |
Why?
|
| Zygapophyseal Joint | 1 | 2018 | 128 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1154 | 0.130 |
Why?
|
| Skeleton | 1 | 2016 | 29 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2017 | 569 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2023 | 9000 | 0.130 |
Why?
|
| Ligands | 5 | 2022 | 3272 | 0.130 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 1749 | 0.130 |
Why?
|
| Homeostasis | 2 | 2021 | 3323 | 0.130 |
Why?
|
| Protease Inhibitors | 2 | 2010 | 754 | 0.130 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 2 | 2013 | 53 | 0.130 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 39106 | 0.130 |
Why?
|
| Stromal Cells | 5 | 2017 | 1330 | 0.120 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 529 | 0.120 |
Why?
|
| Duodenum | 1 | 2018 | 490 | 0.120 |
Why?
|
| Anabolic Agents | 2 | 2008 | 256 | 0.120 |
Why?
|
| Boronic Acids | 2 | 2010 | 915 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2024 | 8002 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2161 | 0.120 |
Why?
|
| Electromyography | 3 | 2023 | 1394 | 0.120 |
Why?
|
| Receptors, Parathyroid Hormone | 2 | 2022 | 332 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 619 | 0.120 |
Why?
|
| Secondary Prevention | 3 | 2022 | 1475 | 0.120 |
Why?
|
| Arthritis, Experimental | 1 | 2017 | 291 | 0.120 |
Why?
|
| Dairy Products | 1 | 2018 | 490 | 0.120 |
Why?
|
| Energy Metabolism | 4 | 2022 | 2882 | 0.120 |
Why?
|
| Mice, Inbred C3H | 6 | 2008 | 915 | 0.120 |
Why?
|
| Acromegaly | 1 | 2017 | 310 | 0.120 |
Why?
|
| Demography | 2 | 2017 | 1648 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2008 | 484 | 0.120 |
Why?
|
| Thermogenesis | 2 | 2021 | 475 | 0.110 |
Why?
|
| GATA1 Transcription Factor | 2 | 2013 | 296 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2024 | 4159 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2022 | 1202 | 0.110 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 320 | 0.110 |
Why?
|
| Foraminifera | 1 | 2013 | 3 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 1099 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 36426 | 0.110 |
Why?
|
| Podocytes | 1 | 2018 | 405 | 0.110 |
Why?
|
| Cell Lineage | 4 | 2014 | 2555 | 0.110 |
Why?
|
| Retina | 1 | 2024 | 2659 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2020 | 0.110 |
Why?
|
| Forearm | 2 | 2008 | 427 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 545 | 0.110 |
Why?
|
| Anatomy, Comparative | 1 | 2013 | 4 | 0.110 |
Why?
|
| Minerals | 2 | 2013 | 283 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2014 | 420 | 0.110 |
Why?
|
| Myography | 1 | 2014 | 111 | 0.110 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2416 | 0.110 |
Why?
|
| Pyrazines | 2 | 2010 | 1201 | 0.110 |
Why?
|
| Adiposity | 4 | 2017 | 1878 | 0.110 |
Why?
|
| Postural Balance | 2 | 2015 | 622 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 490 | 0.110 |
Why?
|
| Species Specificity | 3 | 2013 | 2414 | 0.110 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 598 | 0.110 |
Why?
|
| Longevity | 1 | 2021 | 1065 | 0.110 |
Why?
|
| Gait | 2 | 2022 | 814 | 0.110 |
Why?
|
| Geologic Sediments | 1 | 2013 | 80 | 0.110 |
Why?
|
| Bone Cements | 2 | 2006 | 325 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2021 | 1203 | 0.100 |
Why?
|
| Melanocortins | 1 | 2012 | 10 | 0.100 |
Why?
|
| Spinal Fusion | 1 | 2022 | 1286 | 0.100 |
Why?
|
| Wnt Proteins | 4 | 2011 | 718 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 6216 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2021 | 12128 | 0.100 |
Why?
|
| Recovery of Function | 2 | 2022 | 2979 | 0.100 |
Why?
|
| Insulin Resistance | 3 | 2016 | 3963 | 0.100 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 11903 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2012 | 52 | 0.100 |
Why?
|
| Propranolol | 2 | 2022 | 489 | 0.100 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 243 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 554 | 0.100 |
Why?
|
| Bed Rest | 1 | 2012 | 83 | 0.100 |
Why?
|
| Mass Screening | 1 | 2008 | 5428 | 0.100 |
Why?
|
| Corticosterone | 1 | 2013 | 305 | 0.100 |
Why?
|
| Siblings | 2 | 2007 | 825 | 0.100 |
Why?
|
| Lumbosacral Region | 2 | 2022 | 293 | 0.100 |
Why?
|
| Glucose Intolerance | 2 | 2013 | 575 | 0.100 |
Why?
|
| Peptides | 6 | 2024 | 4358 | 0.100 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 258 | 0.100 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 129 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2007 | 1084 | 0.100 |
Why?
|
| Osteoprotegerin | 3 | 2012 | 176 | 0.100 |
Why?
|
| Hardness | 1 | 2011 | 35 | 0.100 |
Why?
|
| Geriatric Assessment | 2 | 2017 | 1410 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 1349 | 0.090 |
Why?
|
| Receptors, LDL | 2 | 2004 | 488 | 0.090 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2011 | 162 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2012 | 215 | 0.090 |
Why?
|
| Wrist Joint | 1 | 2013 | 267 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2012 | 615 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1405 | 0.090 |
Why?
|
| Blood Glucose | 5 | 2020 | 6391 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2020 | 2691 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2759 | 0.090 |
Why?
|
| Oxidative Stress | 3 | 2024 | 3113 | 0.090 |
Why?
|
| Quality of Life | 3 | 2022 | 13367 | 0.090 |
Why?
|
| Age Distribution | 3 | 2016 | 2880 | 0.090 |
Why?
|
| Humerus | 2 | 2021 | 272 | 0.090 |
Why?
|
| Reference Values | 3 | 2023 | 4920 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2021 | 1234 | 0.090 |
Why?
|
| Circadian Rhythm | 2 | 2013 | 2576 | 0.090 |
Why?
|
| Synchrotrons | 1 | 2010 | 39 | 0.090 |
Why?
|
| Cell Line | 7 | 2020 | 15601 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3530 | 0.090 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2526 | 0.090 |
Why?
|
| Menstrual Cycle | 2 | 2024 | 539 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2018 | 1063 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2021 | 12341 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2017 | 1835 | 0.090 |
Why?
|
| Bone Nails | 2 | 2009 | 220 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 2850 | 0.090 |
Why?
|
| Genetic Linkage | 2 | 2007 | 2341 | 0.080 |
Why?
|
| Type C Phospholipases | 1 | 2010 | 287 | 0.080 |
Why?
|
| Adolescent Development | 1 | 2013 | 282 | 0.080 |
Why?
|
| Rotation | 3 | 2020 | 517 | 0.080 |
Why?
|
| Ephrins | 1 | 2009 | 28 | 0.080 |
Why?
|
| Sternum | 1 | 2010 | 175 | 0.080 |
Why?
|
| Eye | 1 | 2013 | 712 | 0.080 |
Why?
|
| Receptors, Eph Family | 1 | 2009 | 45 | 0.080 |
Why?
|
| Anisotropy | 1 | 2013 | 1283 | 0.080 |
Why?
|
| Health Behavior | 1 | 2001 | 2643 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1670 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15842 | 0.080 |
Why?
|
| Extracellular Matrix | 3 | 2021 | 1726 | 0.080 |
Why?
|
| United States | 9 | 2024 | 72334 | 0.080 |
Why?
|
| Receptors, Calcitonin | 1 | 2008 | 34 | 0.080 |
Why?
|
| Ecosystem | 1 | 2013 | 490 | 0.080 |
Why?
|
| Oxytocin | 1 | 2013 | 402 | 0.080 |
Why?
|
| Liver | 5 | 2016 | 7529 | 0.080 |
Why?
|
| Treatment Outcome | 11 | 2024 | 64680 | 0.080 |
Why?
|
| External Fixators | 1 | 2009 | 99 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.080 |
Why?
|
| Skinfold Thickness | 1 | 2008 | 162 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2023 | 41487 | 0.080 |
Why?
|
| Bony Callus | 3 | 2006 | 41 | 0.080 |
Why?
|
| Drug Therapy, Combination | 6 | 2021 | 6310 | 0.080 |
Why?
|
| Osteocalcin | 4 | 2015 | 274 | 0.080 |
Why?
|
| Takifugu | 1 | 2008 | 7 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2010 | 478 | 0.080 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2005 | 77 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2015 | 6240 | 0.080 |
Why?
|
| Random Allocation | 4 | 2021 | 2395 | 0.080 |
Why?
|
| Aluminum | 1 | 2008 | 152 | 0.070 |
Why?
|
| Cattle | 3 | 2008 | 3849 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2013 | 803 | 0.070 |
Why?
|
| Calcium, Dietary | 3 | 2021 | 529 | 0.070 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2008 | 107 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2020 | 8320 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2011 | 1115 | 0.070 |
Why?
|
| Casts, Surgical | 1 | 2009 | 183 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14666 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2010 | 273 | 0.070 |
Why?
|
| Calpain | 1 | 2008 | 146 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2013 | 999 | 0.070 |
Why?
|
| Locomotion | 1 | 2010 | 388 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2007 | 3395 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 1413 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 263 | 0.070 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2016 | 543 | 0.070 |
Why?
|
| Equipment Design | 2 | 2010 | 3510 | 0.070 |
Why?
|
| Fetal Development | 1 | 2013 | 769 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2010 | 2281 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2009 | 10766 | 0.070 |
Why?
|
| Environment | 1 | 2013 | 1123 | 0.070 |
Why?
|
| Hormones | 1 | 2011 | 869 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 3032 | 0.070 |
Why?
|
| HEK293 Cells | 4 | 2021 | 4278 | 0.070 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 836 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2735 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2012 | 1004 | 0.070 |
Why?
|
| Stem Cells | 2 | 2018 | 3522 | 0.070 |
Why?
|
| Disease Progression | 3 | 2018 | 13506 | 0.070 |
Why?
|
| Surface Properties | 1 | 2009 | 1161 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 1943 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 1136 | 0.070 |
Why?
|
| Drug Administration Schedule | 3 | 2009 | 4853 | 0.070 |
Why?
|
| Feces | 1 | 2013 | 1497 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 1091 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2008 | 235 | 0.070 |
Why?
|
| Lifting | 1 | 2006 | 55 | 0.070 |
Why?
|
| Placebos | 3 | 2015 | 1667 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 80636 | 0.070 |
Why?
|
| Mutation | 8 | 2021 | 30052 | 0.060 |
Why?
|
| Fracture Fixation | 2 | 2007 | 366 | 0.060 |
Why?
|
| Recurrence | 3 | 2021 | 8465 | 0.060 |
Why?
|
| Elastic Modulus | 2 | 2018 | 211 | 0.060 |
Why?
|
| Software | 2 | 2016 | 4434 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 8181 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2018 | 3188 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2019 | 2678 | 0.060 |
Why?
|
| Kinetics | 2 | 2023 | 6374 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 12463 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2005 | 585 | 0.060 |
Why?
|
| Logistic Models | 2 | 2013 | 13255 | 0.060 |
Why?
|
| Hand | 2 | 2004 | 902 | 0.060 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2007 | 280 | 0.060 |
Why?
|
| Hypercalcemia | 1 | 2008 | 423 | 0.060 |
Why?
|
| Testosterone | 3 | 2023 | 2472 | 0.060 |
Why?
|
| Diet | 5 | 2012 | 8075 | 0.060 |
Why?
|
| Adipogenesis | 2 | 2018 | 368 | 0.060 |
Why?
|
| Weight Loss | 3 | 2023 | 2684 | 0.060 |
Why?
|
| Phylogeny | 1 | 2013 | 2811 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2019 | 561 | 0.060 |
Why?
|
| Skull | 2 | 2017 | 818 | 0.060 |
Why?
|
| Megakaryocytes | 2 | 2013 | 566 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17904 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 672 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7827 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5840 | 0.060 |
Why?
|
| Injections, Subcutaneous | 4 | 2007 | 681 | 0.060 |
Why?
|
| Amino Acids | 1 | 2010 | 1718 | 0.060 |
Why?
|
| Somatomedins | 2 | 2021 | 179 | 0.060 |
Why?
|
| Insulin | 2 | 2012 | 6596 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 903 | 0.060 |
Why?
|
| Analysis of Variance | 6 | 2014 | 6228 | 0.060 |
Why?
|
| Cold Temperature | 2 | 2021 | 785 | 0.060 |
Why?
|
| Pain | 1 | 2019 | 5073 | 0.060 |
Why?
|
| Risk Reduction Behavior | 2 | 2020 | 1112 | 0.060 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 992 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2243 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1386 | 0.060 |
Why?
|
| Finger Joint | 1 | 2004 | 108 | 0.060 |
Why?
|
| Cell Count | 3 | 2017 | 1835 | 0.060 |
Why?
|
| Limb Deformities, Congenital | 1 | 2004 | 136 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 857 | 0.050 |
Why?
|
| Heparin | 1 | 2011 | 1634 | 0.050 |
Why?
|
| Fibula | 1 | 2006 | 266 | 0.050 |
Why?
|
| Gonadal Hormones | 1 | 2023 | 30 | 0.050 |
Why?
|
| Eating | 1 | 2010 | 1539 | 0.050 |
Why?
|
| Lod Score | 1 | 2003 | 600 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8547 | 0.050 |
Why?
|
| Seafood | 1 | 2006 | 393 | 0.050 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 2016 | 0.050 |
Why?
|
| Cell Proliferation | 6 | 2019 | 10445 | 0.050 |
Why?
|
| RNA, Messenger | 6 | 2018 | 12795 | 0.050 |
Why?
|
| Multiple Myeloma | 3 | 2021 | 5146 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2024 | 366 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 3085 | 0.050 |
Why?
|
| Sympathetic Nervous System | 2 | 2017 | 518 | 0.050 |
Why?
|
| Base Sequence | 3 | 2014 | 12441 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1494 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2008 | 897 | 0.050 |
Why?
|
| Glucose | 3 | 2012 | 4346 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 2 | 2017 | 471 | 0.050 |
Why?
|
| Isometric Contraction | 1 | 2022 | 150 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2715 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2455 | 0.050 |
Why?
|
| Fracture Fixation, Internal | 1 | 2009 | 973 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2024 | 726 | 0.050 |
Why?
|
| Bone Matrix | 1 | 2002 | 120 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 136 | 0.050 |
Why?
|
| Disease Management | 1 | 2013 | 2508 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2023 | 826 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2008 | 208 | 0.050 |
Why?
|
| Pregnancy | 3 | 2013 | 29874 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2024 | 820 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 764 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 16981 | 0.050 |
Why?
|
| Medicare | 1 | 2020 | 6770 | 0.050 |
Why?
|
| Chondrocytes | 2 | 2019 | 795 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3617 | 0.050 |
Why?
|
| Ligaments, Articular | 1 | 2004 | 302 | 0.050 |
Why?
|
| Cell Communication | 2 | 2011 | 1657 | 0.050 |
Why?
|
| Calcifediol | 1 | 2022 | 161 | 0.050 |
Why?
|
| Phosphates | 1 | 2005 | 770 | 0.050 |
Why?
|
| Quadriceps Muscle | 1 | 2022 | 156 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2021 | 235 | 0.050 |
Why?
|
| Uterus | 1 | 2005 | 649 | 0.050 |
Why?
|
| Orchiectomy | 1 | 2023 | 463 | 0.050 |
Why?
|
| Torsion Abnormality | 3 | 2007 | 91 | 0.050 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.050 |
Why?
|
| Prednisolone | 1 | 2002 | 326 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2014 | 8631 | 0.050 |
Why?
|
| Fruit | 1 | 2006 | 1160 | 0.050 |
Why?
|
| Cell Movement | 4 | 2017 | 5203 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2021 | 117 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2021 | 192 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2007 | 1079 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2016 | 4792 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2008 | 1995 | 0.040 |
Why?
|
| Plasmacytoma | 1 | 2021 | 171 | 0.040 |
Why?
|
| Skin | 1 | 2014 | 4484 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 1241 | 0.040 |
Why?
|
| Myelopoiesis | 1 | 2021 | 134 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5671 | 0.040 |
Why?
|
| Ankle | 1 | 2023 | 351 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3624 | 0.040 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 65 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2002 | 379 | 0.040 |
Why?
|
| Ovary | 1 | 2024 | 959 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2024 | 702 | 0.040 |
Why?
|
| Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
| Osteogenesis, Distraction | 1 | 2002 | 227 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 1039 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1342 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3396 | 0.040 |
Why?
|
| Desogestrel | 1 | 2018 | 17 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 713 | 0.040 |
Why?
|
| Chromosomes | 1 | 2002 | 577 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 15936 | 0.040 |
Why?
|
| Transdermal Patch | 1 | 2018 | 51 | 0.040 |
Why?
|
| Apoptosis | 5 | 2014 | 9486 | 0.040 |
Why?
|
| Finger Phalanges | 1 | 1999 | 41 | 0.040 |
Why?
|
| Moon | 1 | 2018 | 5 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7856 | 0.040 |
Why?
|
| Exercise Therapy | 2 | 2022 | 929 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2000 | 490 | 0.040 |
Why?
|
| Morphine | 1 | 2022 | 657 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 221 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2021 | 607 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2021 | 497 | 0.040 |
Why?
|
| Ethinyl Estradiol | 1 | 2018 | 113 | 0.040 |
Why?
|
| Centrifugation | 1 | 2018 | 122 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 450 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 2917 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 1076 | 0.040 |
Why?
|
| Carrier Proteins | 3 | 2006 | 4936 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3802 | 0.040 |
Why?
|
| Body Size | 2 | 2013 | 463 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2019 | 385 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 1974 | 0.040 |
Why?
|
| Prognosis | 5 | 2020 | 29625 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2021 | 599 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2022 | 1736 | 0.040 |
Why?
|
| Bone Transplantation | 1 | 2022 | 929 | 0.040 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 2491 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2002 | 1336 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3702 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2014 | 2626 | 0.040 |
Why?
|
| Supine Position | 1 | 2017 | 205 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3810 | 0.030 |
Why?
|
| Lead | 1 | 2022 | 879 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5796 | 0.030 |
Why?
|
| Interleukins | 1 | 2021 | 782 | 0.030 |
Why?
|
| Dogs | 1 | 2021 | 3839 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 1738 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 1386 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2010 | 416 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2014 | 1893 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4544 | 0.030 |
Why?
|
| Software Design | 1 | 2016 | 171 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1530 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2016 | 44 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 1265 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 369 | 0.030 |
Why?
|
| Epidemiologic Research Design | 1 | 2019 | 368 | 0.030 |
Why?
|
| Office Visits | 1 | 2000 | 595 | 0.030 |
Why?
|
| Metabolomics | 2 | 2016 | 1659 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5869 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7390 | 0.030 |
Why?
|
| China | 3 | 2006 | 2369 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2856 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 82 | 0.030 |
Why?
|
| Hypopituitarism | 1 | 2017 | 250 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 119 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 3429 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 435 | 0.030 |
Why?
|
| Cosmetics | 1 | 2016 | 102 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2014 | 2919 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2016 | 175 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 88 | 0.030 |
Why?
|
| Protein Binding | 4 | 2011 | 9351 | 0.030 |
Why?
|
| Lipids | 1 | 2006 | 3341 | 0.030 |
Why?
|
| Risk | 3 | 2013 | 9610 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5035 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 473 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2021 | 3415 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 522 | 0.030 |
Why?
|
| Clodronic Acid | 1 | 2014 | 59 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2014 | 405 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1638 | 0.030 |
Why?
|
| Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
| Bahamas | 1 | 2013 | 9 | 0.030 |
Why?
|
| Genome, Human | 1 | 2007 | 4425 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 6075 | 0.030 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2004 | 118 | 0.030 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2013 | 57 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1347 | 0.030 |
Why?
|
| Vitamins | 1 | 2021 | 1635 | 0.030 |
Why?
|
| Fossils | 1 | 2013 | 75 | 0.030 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1519 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 1903 | 0.030 |
Why?
|
| beta Catenin | 2 | 2011 | 1040 | 0.030 |
Why?
|
| Menopause | 3 | 2006 | 1646 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 2013 | 507 | 0.030 |
Why?
|
| Seawater | 1 | 2013 | 124 | 0.030 |
Why?
|
| Population Density | 1 | 2013 | 193 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8529 | 0.030 |
Why?
|
| Head-Down Tilt | 1 | 2012 | 65 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 492 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 642 | 0.030 |
Why?
|
| Densitometry | 1 | 2012 | 151 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 481 | 0.030 |
Why?
|
| Heterozygote | 2 | 2012 | 2787 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9420 | 0.030 |
Why?
|
| Child | 5 | 2021 | 80153 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2012 | 395 | 0.020 |
Why?
|
| Chromosome Mapping | 3 | 2007 | 4615 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2016 | 1699 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 645 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 519 | 0.020 |
Why?
|
| Ilium | 1 | 2012 | 155 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2021 | 2571 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2008 | 4686 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2016 | 1998 | 0.020 |
Why?
|
| Massachusetts | 3 | 2012 | 8830 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3792 | 0.020 |
Why?
|
| Independent Living | 1 | 2015 | 579 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2009 | 6132 | 0.020 |
Why?
|
| Phosphorus | 1 | 2012 | 336 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 598 | 0.020 |
Why?
|
| Gene Transfer Techniques | 2 | 2007 | 1206 | 0.020 |
Why?
|
| Injections | 2 | 2004 | 830 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2016 | 2927 | 0.020 |
Why?
|
| Genotype | 4 | 2008 | 12990 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 714 | 0.020 |
Why?
|
| Paraproteins | 1 | 2010 | 38 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 13446 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 365 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4021 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 2425 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4575 | 0.020 |
Why?
|
| Alleles | 3 | 2008 | 6863 | 0.020 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2010 | 55 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4740 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 1741 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2449 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
| Physical Endurance | 1 | 1992 | 366 | 0.020 |
Why?
|
| Sheep | 1 | 2012 | 1440 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1827 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1178 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1062 | 0.020 |
Why?
|
| Drug Carriers | 2 | 2004 | 706 | 0.020 |
Why?
|
| Hand Strength | 1 | 2012 | 456 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2011 | 1085 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2176 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 5492 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 802 | 0.020 |
Why?
|
| Housing for the Elderly | 1 | 2008 | 17 | 0.020 |
Why?
|
| Triglycerides | 1 | 2017 | 2461 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2008 | 87 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 542 | 0.020 |
Why?
|
| Cyclohexenes | 1 | 2008 | 15 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 862 | 0.020 |
Why?
|
| Vinyl Compounds | 1 | 2008 | 22 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2011 | 419 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2017 | 984 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 4915 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1705 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2008 | 139 | 0.020 |
Why?
|
| Androstenedione | 1 | 2008 | 131 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Prevalence | 2 | 2018 | 15732 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2490 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2003 | 6567 | 0.020 |
Why?
|
| Minnesota | 1 | 2008 | 338 | 0.020 |
Why?
|
| Myositis Ossificans | 1 | 2008 | 77 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2012 | 743 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 745 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4758 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 161 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 51 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2007 | 110 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2008 | 295 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2231 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1971 | 0.020 |
Why?
|
| Calcitonin | 1 | 2008 | 329 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2010 | 2690 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2007 | 421 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2012 | 4174 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 1460 | 0.020 |
Why?
|
| Half-Life | 1 | 2007 | 651 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9606 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3808 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 1702 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 944 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 516 | 0.020 |
Why?
|
| Puberty | 1 | 2009 | 501 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3595 | 0.020 |
Why?
|
| Isomerism | 1 | 2005 | 197 | 0.020 |
Why?
|
| Microscopy, Polarization | 1 | 2005 | 89 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3194 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2007 | 305 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2831 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 818 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1341 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 280 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 838 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 1570 | 0.020 |
Why?
|
| Ointments | 1 | 2004 | 58 | 0.020 |
Why?
|
| Genes, APC | 1 | 2005 | 145 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 484 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6766 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2004 | 58 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1880 | 0.010 |
Why?
|
| NF-E2 Transcription Factor | 1 | 2003 | 38 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2005 | 181 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5336 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
| Rural Health | 1 | 2005 | 296 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2423 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2008 | 1687 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2004 | 263 | 0.010 |
Why?
|
| Macrophages | 1 | 2018 | 5769 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21012 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2007 | 1463 | 0.010 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2008 | 499 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1509 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2003 | 240 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2011 | 2049 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1202 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3602 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5247 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2008 | 3615 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2010 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2006 | 1755 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 1967 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 749 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2007 | 3597 | 0.010 |
Why?
|
| Actins | 1 | 2008 | 2050 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 2651 | 0.010 |
Why?
|
| Heart Rate | 1 | 2012 | 4195 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3548 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1257 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3579 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17635 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 2518 | 0.010 |
Why?
|
| Aorta | 1 | 2008 | 2042 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9326 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 1408 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 1273 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 1776 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2065 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2448 | 0.010 |
Why?
|
| Extremities | 1 | 2004 | 867 | 0.010 |
Why?
|
| Proteins | 1 | 2014 | 6032 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 2226 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 1733 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5305 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2819 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 2825 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2265 | 0.010 |
Why?
|
| Weight Gain | 1 | 2008 | 2348 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 2009 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10090 | 0.010 |
Why?
|
| Uric Acid | 1 | 2003 | 807 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 5791 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2008 | 3028 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4465 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3778 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3492 | 0.010 |
Why?
|
| Rural Population | 1 | 2006 | 2285 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2008 | 3905 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2005 | 2598 | 0.010 |
Why?
|
| Research Design | 1 | 2010 | 6180 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 6485 | 0.010 |
Why?
|
| Kidney | 1 | 2008 | 7048 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 2319 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 3442 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11076 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5789 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13639 | 0.000 |
Why?
|